Elizabeth Le1, Hongquan Zhang, George Blanck. 1. Department of Biochemistry and Molecular Biology, College of Medicine, University of South Florida, Tampa, Florida 33612, USA.
Abstract
BACKGROUND: Cell-surface major histocompatibility (MHC) class II molecules contribute to a molecular, intercellular complex that stimulates T-cells. MHC class II molecules also activate signaling pathways leading to apoptosis. Lack of CIITA, a co-activator of the MHC class II gene promoter, is responsible for lack of MHC class II on most of the MHC class II-negative melanoma cell lines. MATERIALS AND METHODS: We rescued CIITA and MHC class II expression in melanoma cell lines by stable transformation with a CIITA expression vector and assayed for MHC class II-mediated apoptosis. RESULTS: Reconstitution of CIITA in multiple CIITA-negative melanoma lines restores the apoptotic function of melanoma MHC class II. CONCLUSION: Lack of MHC class II transcription, rather than defects in MHC class II protein function or defects in the other components of the MHC class II-stimulated apoptotic pathway, prevents MHC class II-mediated apoptosis in melanoma cells.
BACKGROUND: Cell-surface major histocompatibility (MHC) class II molecules contribute to a molecular, intercellular complex that stimulates T-cells. MHC class II molecules also activate signaling pathways leading to apoptosis. Lack of CIITA, a co-activator of the MHC class II gene promoter, is responsible for lack of MHC class II on most of the MHC class II-negative melanoma cell lines. MATERIALS AND METHODS: We rescued CIITA and MHC class II expression in melanoma cell lines by stable transformation with a CIITA expression vector and assayed for MHC class II-mediated apoptosis. RESULTS: Reconstitution of CIITA in multiple CIITA-negative melanoma lines restores the apoptotic function of melanoma MHC class II. CONCLUSION: Lack of MHC class II transcription, rather than defects in MHC class II protein function or defects in the other components of the MHC class II-stimulated apoptotic pathway, prevents MHC class II-mediated apoptosis in melanoma cells.
Authors: Kevin Cronin; Hernando Escobar; Karoly Szekeres; Eduardo Reyes-Vargas; Alan L Rockwood; Mark C Lloyd; Julio C Delgado; George Blanck Journal: Hum Vaccin Immunother Date: 2013-01-17 Impact factor: 3.452